VESPER-2 is a 28-week Phase 2b clinical trial assessing the efficacy and tolerability of different weekly doses of MET-097i with or without titration. The trial enrolled the first participant in March ...

The people who purchase the shares at the IPO price can gain by selling those when they increase in value after listing. IPOs provide financial fuel while enabling the public to invest alongside a ...

ESDS Software, a cloud services and data center firm, plans to raise up to Rs 700 crore through an IPO, filing its draft red herring prospectus with SEBI. The proceeds will expand data centers, invest ...